Agricultural farm workers exposed to aerosols of organic compounds are at risk of developing respiratory abnormalities. The Grain Weevil, a parasite infecting grain, is a frequent contaminant of processed wheat. We studied the effect of grain weevil extract (GWE) on isolated guinea pig trachea (GPT) smooth muscle in order to investigate the potential bronchoconstrictor properties of this organic agent. GWE was prepared as a 1:10 w/v solution. The extract was added to GPT in a series of 12 organ baths, in parallel, in 1/2 log dose increments. Dose related contractions of GPT were demonstrated using GWE. Tissue response was measured as a percent of the tissue's maximal contraction to carbachol. The effects of mediator modifying drugs including atropine, indomethacin, pyrilamine (H1 antagonist), acivicin, NDGA, and BPB (which block segments of the arichidonic acid cascade),TMB8 (blocks intracellular calcium mobilization) capsaicin (depletes irritant nerve mediators) and captopril (ACE inhibitor) were tested by pre-treating the tissues with these agents. Endotoxin content of the dust extract was, 2014 EU/mg. Protein analysis revealed 55 mcg/mg of extract. Atropine completely blocked the contractile response of GWE. Pyrilamine, acivicin, BPB, capsaicin, captopril and TMB8 significantly reduced the contractile effects of GWE (p<0.05).As with other organic dusts previously studied, GWE appears to cause a non-immunologically mediated constriction of airway smooth muscle modulated by mediators of inflammation. The cholinergic receptor is prominently involved in this effect. These findings may be related to respiratory abnormalities seen in agricultural workers processing grain.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.